SCHEMBL140392

SCHEMBL140392

O=P(O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.64
BLM P54132 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
BTN3A1 O00481 4/20 0.42
MVD P53602 3/20 0.37
CA4 P22748 1/20 0.33
FNTA P49354 2/20 0.32
FNTB P49356 1/20 0.32
PGGT1B P53609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45357 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL8851949 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL10834666 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL28494654 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL897837 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL554667 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL36089 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
SCHEMBL28767268 1.00 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
Ammonia Solution, Strong SCHEMBL21679659 0.96 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD
Ammonia Solution, Strong SCHEMBL21679658 0.96 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1836 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085168-A1 PLANT FIBRE PRODUCT Beyondwood Coöperation U.A. (NL) 2026-03-26 US claimed
US-12467085-B2 High accuracy nanopore-based single molecule sequencing by synthesis with tagged nucleotides THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-11-11 US claimed
EP-4587503-A1 PLANT FIBRE PRODUCT Beyondwood Coöperation U.A. (NL) 2025-07-23 EP claimed
US-20250222132-A1 NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME BioNTech SE (DE) 2025-07-10 US claimed
WO-2025133105-A1 COMPOSITIONS AND METHODS BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2025-06-26 WO claimed
CN-114846149-B Methods and kits for template independent nucleic acid synthesis 陈呈尧 2025-06-10 CN claimed
US-20250169521-A1 COMPOSITIONS AND METHODS FOR INCREASING THE PALATABILITY OF DRY PET FOOD Société des Produits Nestlé S.A. (CH) 2025-05-29 US claimed
EP-4504158-A1 NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME BioNTech SE (DE) 2025-02-12 EP claimed
EP-3699271-B1 GRANULE AND PELLET COMPOSITIONS COMPRISING PHYTASE AND PHYTIC ACID AND PREPARATION METHOD DANISCO US INC (US) 2024-09-25 EP claimed
US-20240158425-A1 MODIFIED ADENINES NUCLERA LTD (GB) 2024-05-16 US claimed
CN-86104458-A With affinity chromatography purifying haemachrome and improvement haemachrome 1987-07-01 CN claimed
WO-1987000177-A1 PURIFICATION OF HEMOGLOBIN AND MODIFIED HEMOGLOBIN BY AFFINITY CHROMATOGRAPHY HEMOSOL INC. (CA) 1987-01-15 WO claimed
EP-0101341-B1 PROCESS AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR HEMOGLOBIN ALLOSTERIC EFFECTORS, AND ERYTHROCYTES SO OBTAINED Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1986-11-05 EP claimed
EP-0022757-B1 METHOD FOR DETERMINING CREATINE KINASE IN SAMPLES CONTAINING ATP LKB-Produkter AB (SE) 1984-09-19 EP claimed
EP-0101341-A1 Process and device for the encapsulation in erythrocytes of at least one biologically active substance, in particular hemoglobin allosteric effectors, and erythrocytes so obtained Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1984-02-22 EP claimed
EP-0015437-B1 METHOD AND REAGENT FOR THE DETERMINATION OF CREATINE KINASE Roche Diagnostics GmbH (DE) 1981-11-25 EP claimed
EP-0008341-B1 METHOD AND REAGENT FOR ENZYMATIC DETERMINATIONS AND TEST KIT FOR THIS METHOD Roche Diagnostics GmbH (DE) 1981-11-04 EP claimed
EP-0001104-B1 MODIFIED INTACT ERYTHROCYTES, BLOOD OR BLOOD PRESERVES CONTAINING THEM AND PROCESS FOR THEIR PREPARATION Studiengesellschaft Kohle mbH (DE) 1981-05-20 EP claimed
US-4249141-A Laser systems using pentaphosphate active mediums UNIVERSITY OF ROCHESTER (US) 1981-02-03 US claimed
US-4195226-A Luminescent material and preparation and use thereof MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 1980-03-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085168-A1 PLANT FIBRE PRODUCT PRRC2C, SYMPK, PIP5K1C FDPS 319/4885BLM 265/4885TDP1 965/4885
US-20250222132-A1 NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME NSUN3, RNGTT, SNRPA1 FDPS 2580/4885BLM 329/4885TDP1 291/4885
US-20240158425-A1 MODIFIED ADENINES RNGTT, ADAR, MRM1 FDPS 1081/4885BLM 591/4885TDP1 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.